Cargando…
Repressing CD147 is a novel therapeutic strategy for malignant melanoma
CD147/basigin, a transmembrane protein, is a member of the immunoglobulin super family. Accumulating evidence has revealed the role of CD147 in the development and progression of various cancers, including malignant melanoma (MM). MM is a malignancy of pigment-producing cells that causes the greates...
Autores principales: | Hu, Xing, Su, Juan, Zhou, Youyou, Xie, Xiaoyun, Peng, Cong, Yuan, Zhimin, Chen, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421970/ https://www.ncbi.nlm.nih.gov/pubmed/28445958 http://dx.doi.org/10.18632/oncotarget.15709 |
Ejemplares similares
-
Novel Functions of CD147 in the Mitochondria Exacerbates Melanoma Metastasis
por: Lu, Lixia, et al.
Publicado: (2021) -
Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression
por: Zhao, Shuang, et al.
Publicado: (2018) -
CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma
por: Su, Juan, et al.
Publicado: (2016) -
CD147 mediates epidermal malignant transformation through the RSK2/AP-1 pathway
por: Zhang, Xu, et al.
Publicado: (2022) -
Nuclear envelope-distributed CD147 interacts with and inhibits the transcriptional function of RING1 and promotes melanoma cell motility
por: Chen, Junchen, et al.
Publicado: (2017)